Share Name Share Symbol Market Type Share ISIN Share Description
Syncona LSE:SYNC London Ordinary Share GG00B8P59C08 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 146.60p 146.00p 147.50p - - - 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 11.9 5.9 1.5 95.8 965.64

Syncona Share Discussion Threads

Showing 18251 to 18273 of 18275 messages
Chat Pages: 731  730  729  728  727  726  725  724  723  722  721  720  Older
DateSubjectAuthorDiscuss
25/3/2017
00:49
Quite exciting: Blue Earth Diagnostics achieves positive CHMP opinion on Axumin 24 March 2017 * Axumin receives positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, a key milestone in securing European approval * Positive progress in the USA market following the commencement of sales of Axumin in August 2016 * Syncona's investment in Blue Earth Diagnostics written up from GBP83.5 million to GBP109.01 million adding GBP25.5 million (3.9p per share) to Syncona Ltd's NAV Syncona Ltd ("Syncona"), is pleased to note the announcement by its portfolio company Blue Earth Diagnostics Limited ("Blue Earth") that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that Axumin be granted marketing authorisation in the European Union. Syncona holds a 90 per cent interest in the share capital of Blue Earth. The recommendation is for Axumin (fluciclovine 18F) use in Positron Emission Tomography (PET) imaging to detect recurrence of prostate cancer in adult men with a suspected recurrence based on elevated blood prostate specific antigen (PSA) levels after primary curative treatment. This is an area of significant unmet need. A CHMP positive opinion is a key step in achieving approval to sell Axumin in the European Union. The opinion on Axumin will now be reviewed by the European Commission, which has the authority to approve medicines for the European Union. The final decision is expected in the coming months and would be applicable to all European Union member states as well as in Iceland, Liechtenstein and Norway. Axumin was approved by the Food and Drug Administration (FDA) in the United States of America in May 2016, and sales commenced in August 2016.Since this time the business has continued to make good strategic and commercial progress in the region. The positive opinion of the CHMP, coupled with good progress in the USA, has resulted in Syncona's investment in Blue Earth being written up to GBP109.01 million, a GBP25.5 million (3.9p per share) uplift to the last published valuation of GBP83.5 million. Syncona Investment Management partner and Blue Earth director Iraj Ali, said, "In the three years since formation Blue Earth has successfully delivered to the US market a product with the potential to transform how patients with recurrent prostate cancer are treated. It is now a significant step closer to doing the same in Europe, which is testament to the efficacy of the product, hard work of the team and the strength of Syncona's long term partnership model." Blue Earth chief executive, Jonathan Allis, said, "The CHMP's positive recommendation for Axumin is a major advance for Blue Earth. We now look forward to working with our commercial manufacturing and distribution associates to be ready to make Axumin widely available to doctors and their patients across Europe."
rambutan2
06/3/2017
12:56
Good to see that along with a Capital Mkts Day they've launched a proper website today, as befits a ftse 250 investment company. Comprehensive presentation: htTP://www.synconaltd.com/wp-content/uploads/2017/03/Syncona-Capital-Markets-Day-March-2017.pdf
rambutan2
03/3/2017
01:59
Promoted into ftse 250, with effect from mon 20th. http://www.investegate.co.uk/ftse/rns/ftse-uk-index-series/201703011739112850Y/
rambutan2
10/2/2017
13:29
Is 9% of nav: BURLINGTON, Mass. and OXFORD, England February 7, 2017 – Blue Earth Diagnostics, a molecular imaging diagnostics company, and Siemens’ PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc., announce the increasing number of radiopharmacies offering Blue Earth Diagnostics’ Axumin (fluciclovine F 18) PET imaging agent through PETNET’s national network. hTTp://www.blueearthdiagnostics.com/axumin-fluciclovine-f-18-injection-pet-imaging-agent-suspected-recurrent-prostate-cancer/
rambutan2
29/1/2017
03:45
First fact sheet post enlargement and remit change: htTP://content.prnewswire.com/documents/PRNUK-2701171238-5B58_Syncona_Factsheet_December_2016_CC.pdf
rambutan2
29/1/2017
03:45
hTTp://synconaltd.com//wp-content/uploads/BACIT-Limited-Prospectus-28-November-2016.pdf Historical info on Syncona pre BACIT merger: httPS://wellcome.ac.uk/press-release/wellcome-trust-launch-%C2%A3200-million-investment-business-healthcare-and-life-sciences hTTps://wellcome.ac.uk/press-release/launch-syncona-partners httPS://www.bloomberg.com/news/articles/2013-01-03/wellcome-trust-starts-326-million-health-investment-arm htTps://www.cbinsights.com/investor/syncona-partners httPS://www.crunchbase.com/organization/syncona-partners-llp#/entity
rambutan2
29/1/2017
03:43
hTTp://synconaltd.com/ httPs://wellcome.ac.uk/news/syncona-join-forces-leading-investment-trust hTTp://www.cancerresearchuk.org/about-us/cancer-news/press-release/2016-11-07-cancer-research-uk-joins-forces-with-wellcome-trust-syncona-and-bacit-to-create-life-sciences htTP://www.telegraph.co.uk/business/2016/11/07/1bn-fund-to-reignite-uk-life-sciences-companies-with-long-term-f/ Bio investments: hTTp://www.blueearthdiagnostics.com/ httPS://www.nightstarx.com/ httP://www.autolus.com/ hTTp://www.freelinetx.com/ httPS://www.cambridge-epigenetix.com/ hTTp://achillestx.com/ hTtp://sixthelementcapital.com/index.php/portfolio (aka The Pioneer Fund)
rambutan2
30/12/2016
17:51
Use other thread
rambutan2
20/12/2016
15:28
Deja vu...... DL
davidlloyd
27/5/2014
10:48
New MYRN threads have been set up - see links below: hTTp://uk.advfn.com/cmn/fbb/thread.php3?id=32016165 hTTp://uk.advfn.com/cmn/fbb/thread.php3?id=31875170 For all those interested in following this stock perhaps you should migrate across. Thanks.
plunge
26/5/2014
23:40
busy today!!! RNS expected.?
maqsud
19/3/2014
15:12
Annual results tomorrow. Judging by the recent share price performance the market is not expecting much. We shall see.
plunge
07/3/2014
08:29
Good Start !
chinese investor
06/3/2014
12:13
Hopefully the upward momentum can be maintained. I thought we would have heard something more about their Twitter rollout to the emerging markets. Perhaps more will be forthcoming with the release of the annual results on 20th March.
plunge
06/3/2014
11:48
Looking Good !
chinese investor
06/3/2014
08:25
ZURICH, Switzerland – 6th March, 2014 – Myriad Group AG (SIX: MYRN), the company creating and connecting communities across mobile and TV, today announces that Myriad Updates (MU), including its Facebook for USSD service, has successfully launched with Meditel Morocco, a major operator in the Orange Group. Facebook for USSD is now available to subscribers in 20 countries worldwide. Since its launch, over 20 million unique visitors have connected to the service. Facebook for USSD at Meditel has been a tremendous success. Meditel's track record of innovation and its desire to democratise access to Facebook made MU an obvious choice to let all subscribers connect to the social network. Myriad Updates is a ubiquitous, text‐based social mobile messaging service that provides users with simple, low‐cost access to a range of services over USSD that include social networking and messaging. Accessible on any mobile device, subscribers can easily connect to services like Facebook without needing to purchase a data plan, upgrading to a new mobile phone or even downloading an app on their device. Stephen Dunford, CEO of Myriad Group, commented: "We are delighted to be able to support Meditel Morocco as the operator brings new ways to connect to mobile Internet services to its subscribers in an affordable way. Myriad Updates enables mobile users to join the world's largest online social networking communities at minimal cost. Its popularity is certainly underlined by the rapid subscriber uptake in Morocco." Reda Salmane, Product Marketing Manager at Meditel, commented: "Myriad's Facebook for USSD service is the perfect answer to the requirements of the Moroccan market. It meets the needs of our large Facebook users community who are still mostly using feature phones and rarely have internet access on their devices. We are proud of our partnership with Myriad who took our particular needs into account when customising the service ahead of its deployment." About Myriad Myriad delivers consumer applications, messaging solutions, and embedded software to leading OEMs, mobile operators, and pay TV providers worldwide. Our messaging services deliver instant messaging and social networking to tens of millions of users in Latin America, Asia and Africa. Working with some of the world's most successful mobile phone operators, Myriad's market leading chat application, MSNGR, enables consumers to connect to friends and family for free across feature phones as well as smartphones. Our Updates service, provided over USSD, enables users without data plans to connect to the social networks and chat services they want to reach in a simple and affordable way. In many cases, Myriad's services are providing users with their first experience of the Internet. Our market proven and innovative connected home solutions are found in billions of mobile phones and tens of millions of set-top boxes and Blu-ray players.
chinese investor
23/2/2014
19:19
It is about time Stephen Dunford & Co. gave shareholders something to cheer about. To date senior management appears to have been a bit uninspiring.
plunge
23/2/2014
10:36
We are exhibiting at Barcelona next week.
chinese investor
23/2/2014
10:21
Our messaging services deliver email, instant messaging and social networking to tens of millions of users in Latin America, Asia and Africa. Working with some of the world's most successful mobile phone operators, Myriad's market leading services enable consumers to connect to Internet services they want to reach in simple and affordable ways. In many cases, Myriad's services are providing them with their first experience of the Internet.
chinese investor
20/2/2014
07:57
The price tag Facebook has just put on WhatsApp shows the immense value in instant messaging. Hopefully this will give MYRN's share price a boost.
plunge
15/1/2014
09:43
Having taken advantage of last year's rights offer I do hope the upward momentum is maintained. Also the recent volume seems to be encouraging.
plunge
15/1/2014
09:19
Myriad Doing Well ! 2.5p Soon IMO !
chinese investor
14/1/2014
21:49
one to watch ...phenomenal growth play if executed as envisaged by the management.
maqsud
Chat Pages: 731  730  729  728  727  726  725  724  723  722  721  720  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170427 07:15:58